Annual Dallas Conference

Annual Dallas Conference aims to deliver a comprehensive educational update that highlights the most clinically relevant advances in chronic liver and gastrointestinal diseases. The 1.5-day conference will have a strong focus on viral hepatitis, non-alcoholic steatohepatitis, primary biliary cirrhosis, complications of cirrhosis, including hepatic encephalopathy and thrombocytopenia, hepatocellular carcinoma, and irritable bowel syndrome.